Business Context and Reporting Period
Company: Nathan's Famous, Inc. (NATH)
Filing Type: Form 8-K (Current Report)
Date of Report: January 20, 2026
Event: Entry into a definitive agreement to be acquired by Smithfield Foods, Inc. The transaction involves a merger where Nathan's Famous will become a wholly-owned subsidiary of Smithfield and cease to be publicly traded.
Key Financial Metrics and Transaction Terms
Merger Consideration: $102.00 per share in cash for each outstanding share of Nathan's Famous common stock.
Equity Award Treatment:
- Stock Options: Converted to cash equal to the excess of the $102.00 merger price over the exercise price.
- Restricted Stock Units (RSUs):strong> Deemed fully vested and converted to cash equal to the number of shares multiplied by $102.00.
Dividends: The Company is permitted to declare and pay up to two regular quarterly cash dividends of $0.50 per share prior to closing.
Termination Fees:
- Company Fee: $10,581,814 payable to Smithfield if the Company changes its recommendation, fails to obtain stockholder approval after changing recommendation, or accepts a superior proposal within nine months of termination.
- Buyer Fee: $7,407,270 payable to the Company if the deal fails due to a CFIUS denial or government action preventing closing (subject to specific conditions).
Executive Retention Bonuses:
- Eric Gatoff (CEO): $3,250,000
- Robert Steinberg (CFO): $1,050,000
Liquidity/Debt: The filing text does not provide specific values for current revenue, profit, cash flow, margins, or debt levels.
Material Changes and Agreements
Voting Agreement: Smithfield, the Company, the Board, and certain stockholders holding approximately 29.9% of outstanding shares have entered into a Voting Agreement to vote in favor of the merger and against competing proposals.
Licensing Extension: An amendment to the existing licensing and supply agreement with Smithfield Packaged Meats Corp. will extend the term by four years, from March 2, 2032, to March 2, 2036.
No-Shop Provisions: The Company is restricted from soliciting alternative transactions, subject to a fiduciary out allowing engagement with a "Superior Proposal" if the Board determines it is necessary to fulfill fiduciary duties.
Guidance, Outlook, and Risks
Outlook: The Company expects to file a preliminary proxy statement within 45 days of the agreement date. A stockholder meeting will be held no more than 30 days after the definitive proxy is mailed.
Closing Conditions:
- Stockholder approval.
- Expiration of HSR Act waiting periods.
- CFIUS (Committee on Foreign Investment in the United States) clearance.
- Accuracy of representations and warranties.
- No Material Adverse Effect on the Company.
Risks and Contingencies:
- Failure to obtain required stockholder or regulatory approvals (specifically CFIUS).
- Termination of the agreement due to a superior proposal or breach.
- Diversion of management attention from operations.
- Uncertainty regarding the timing of closing.
Investor Verification Checklist
- Proxy Statement: Review the definitive proxy statement for detailed financial data, risk factors, and the full text of the Merger Agreement.
- Regulatory Approvals: Monitor the status of HSR and CFIUS clearances, which are critical closing conditions.
- Stockholder Vote: Confirm the date of the stockholder meeting and the voting requirements for approval.
- Superior Proposal: Assess the likelihood of a competing bid given the "fiduciary out" clause and the $10.58M termination fee.
- Executive Retention: Verify the impact of the $4.3M in retention bonuses on the Company's cash position prior to closing.